论文部分内容阅读
Objective Early identification of patients with poor prognosis has been a crucial thing for clinicians to formulate more comprehensive therapeutic strategies.In this article,we aim to understand the role of serum inflammatory factors,tumor burden indicators,PET/CT maximal standardized uptake value(SUVmax) and immunohistochemical index Ki67 in early prediction of prognosis and survival of patients diagnosed with non-Hodgkins lymphoma(NHL).